According to NantHealth's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.155213. At the end of 2022 the company had a P/S ratio of 0.4197.
Year | P/S ratio | Change |
---|---|---|
2022 | 0.4197 | -78.43% |
2021 | 1.95 | -60.39% |
2020 | 4.91 | 313.73% |
2019 | 1.19 | 78.27% |
2018 | 0.6660 | -81.29% |
2017 | 3.56 | -70.34% |
2016 | 12.0 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Anaplan
PLAN | N/A | N/A | ๐บ๐ธ USA |